» Authors » Rajinder Bajwa

Rajinder Bajwa

Explore the profile of Rajinder Bajwa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 346
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guttoo P, Olsavsky A, Ralph J, Bajwa R, Lipak K, Adewumi A, et al.
J Child Health Care . 2025 Feb; :13674935251324607. PMID: 40009877
This cross-sectional study explores the types of preventive and chronic care survivors of childhood cancer and pediatric bone marrow transplant receive from their primary care providers. We also identified barriers...
2.
Skeens M, Kochashvili M, Benhayoun A, Ralph J, Bajwa R, Vannatta K, et al.
J Pediatr Nurs . 2024 Oct; 79:e132-e140. PMID: 39424444
Background: High rates of medication non-adherence (52-73 %) in pediatric hematopoietic stem cell transplant (HCT), due to complex regimens and forgetfulness, increase life-threatening risks. Purpose: This mixed methods study aimed...
3.
Ragoonanan D, Abdel-Azim H, Sharma A, Bhar S, McArthur J, Madden R, et al.
Lancet Reg Health Am . 2024 Apr; 33:100728. PMID: 38616918
Background: Sinusoidal obstruction syndrome is a potentially fatal complication following hematopoietic cell transplantation, high-intensity chemotherapies and increasingly seen with calicheamicin based leukemia therapies. Paediatric specific European Society for Blood and...
4.
Bowman S, Stanek J, Bajwa R, Polishchuk V, Abu-Arja R, Rangarajan H
Clin Hematol Int . 2023 Apr; 5(2-3):155-164. PMID: 37027103
Patients with poor graft function (PGF) or declining donor chimerism (DC) post allogeneic hematopoietic cell transplantation (HCT) may benefit from a CD34-selected stem cell boost (SCB). We retrospectively studied outcomes...
5.
Di Nardo M, Ahmad A, Merli P, Zinter M, Lehman L, Rowan C, et al.
Lancet Child Adolesc Health . 2021 Dec; 6(2):116-128. PMID: 34895512
Use of extracorporeal membrane oxygenation (ECMO) in children receiving haematopoietic cell transplantation (HCT) and immune effector cell therapy is controversial and evidence-based guidelines have not been established. Remarkable advancements in...
6.
Ragoonanan D, Khazal S, Abdel-Azim H, McCall D, Cuglievan B, Tambaro F, et al.
Nat Rev Clin Oncol . 2021 Mar; 18(7):468. PMID: 33731864
No abstract available.
7.
Ragoonanan D, Khazal S, Abdel-Azim H, McCall D, Cuglievan B, Tambaro F, et al.
Nat Rev Clin Oncol . 2021 Feb; 18(7):435-453. PMID: 33608690
Cancer immunotherapies are associated with remarkable therapeutic response rates but also with unique and severe toxicities, which potentially result in rapid deterioration in health. The number of clinical applications for...
8.
Skeens M, Gerhardt C, Bajwa R, Akard T
Pediatr Transplant . 2020 Jul; 24(6):e13786. PMID: 32678483
Pediatric HSCT patients endure complicated treatment regimens, lifestyle modifications, and a lifetime of long-term follow-up. Treatment adherence in this population is understudied and prevalence unknown. Providers (physicians and advanced practice...
9.
Mahadeo K, Bajwa R, Abdel-Azim H, Lehmann L, Duncan C, Zantek N, et al.
Lancet Haematol . 2019 Dec; 7(1):e61-e72. PMID: 31818728
Sinusoidal obstructive syndrome, also known as hepatic veno-occlusive disease, is a potentially life-threatening complication that occurs in children undergoing haemopoietic stem-cell transplantation (HSCT). Differences in the incidence of genetic predisposition...
10.
Shaw A, Passweg J, de la Fuente J, Bajwa R, Stein J, Al-Zaben A, et al.
Biol Blood Marrow Transplant . 2019 Nov; 26(3):480-485. PMID: 31733299
There have been sporadic reports of the development of delayed disease recurrence after bone marrow transplantation for severe aplastic anemia despite sustained majority or full donor chimerism. This is termed...